Edmund Folefac MD

Associate professor of Medicine, The Ohio State university

Summary

Edmund Folefac, MD, is an oncology specialist based in Columbus, OH, currently serving as an Associate Professor at Ohio State University Wexner Medical Center since 2021 where he completed a fellowship in clinical bioethics. He completed his fellowship in Hematology, Medical Oncology and geriatrics at Boston University Medical Center in 2014 where he also completed a Master of science in clinical investigation and residency in Internal Medicine at MGH-Brigham Northshore in 2007, following his medical education at Obafemi Awolowo College of Health Sciences. Dr. Folefac has co-authored several research publications, including studies on kidney and prostate cancer, with notable works published in journals such as the British Journal of Cancer, Frontiers in oncology, molecular cancer therapeutics and Journal for Immunotherapy of Cancer. His research has been acknowledged in scientific communities, with multiple citations for his studies.

Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
Mass General Brigham/Salem HospitalResidency, Internal Medicine, 2004 - 2007
Obafemi Awolowo College of Health Sciences, Ogun State UniversityClass of 2001

PubMed

Abstracts/Posters

Concurrent Treatment of VEGFR Tyrosine Kinase Inhibitors (TKIs) and Factor Xa Inhibitors Is Associated with Increased Bleeding Risks
Edmund Folefac, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Vast Majority of Americans Don't Know Early PCa Has Zero Symptoms, Ohio State Survey ConfirmsSeptember 28th, 2025
Majority in US Unaware of Early Prostate Cancer Signs, Survey RevealsSeptember 18th, 2025
Experts Say Early Signs of Early Prostate Cancer Are RareAugust 29th, 2025